Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors

BACKGROUND: A precision medicine approach in type 2 diabetes requires identification of clinical and biological features that are reproducibly associated with differences in clinical outcomes with specific anti-hyperglycaemic therapies. Robust evidence of such treatment effect heterogeneity could su...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Katherine G, McInnes, Eram Haider, Massey, Robert J, Kahkohska, Anna R, Pilla, Scott J, Raghaven, Sridharan, Stanislawski, Maggie A, Tobias, Deirdre K, McGovern, Andrew P, Dawed, Adem Y, Jones, Angus G, Pearson, Ewan R, Dennis, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153311/
https://www.ncbi.nlm.nih.gov/pubmed/37131814
http://dx.doi.org/10.1101/2023.04.21.23288868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153311/
https://www.ncbi.nlm.nih.gov/pubmed/37131814
http://dx.doi.org/10.1101/2023.04.21.23288868

Ejemplares similares